2-168904561-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_021176.3(G6PC2):​c.385G>T​(p.Ala129Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000685 in 1,460,244 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )

Consequence

G6PC2
NM_021176.3 missense

Scores

9
10

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.27

Publications

0 publications found
Variant links:
Genes affected
G6PC2 (HGNC:28906): (glucose-6-phosphatase catalytic subunit 2) This gene encodes an enzyme belonging to the glucose-6-phosphatase catalytic subunit family. These enzymes are part of a multicomponent integral membrane system that catalyzes the hydrolysis of glucose-6-phosphate, the terminal step in gluconeogenic and glycogenolytic pathways, allowing the release of glucose into the bloodstream. The family member encoded by this gene is found in pancreatic islets and does not exhibit phosphohydrolase activity, but it is a major target of cell-mediated autoimmunity in diabetes. Several alternatively spliced transcript variants of this gene have been described, but their biological validity has not been determined. [provided by RefSeq, Jul 2008]
SPC25 (HGNC:24031): (SPC25 component of NDC80 kinetochore complex) This gene encodes a protein that may be involved in kinetochore-microtubule interaction and spindle checkpoint activity. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.28753597).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
G6PC2NM_021176.3 linkc.385G>T p.Ala129Ser missense_variant Exon 3 of 5 ENST00000375363.8 NP_066999.1 Q9NQR9-1
G6PC2NM_001081686.2 linkc.385G>T p.Ala129Ser missense_variant Exon 3 of 4 NP_001075155.1 Q9NQR9-3
G6PC2XM_011511565.4 linkc.37G>T p.Ala13Ser missense_variant Exon 2 of 4 XP_011509867.1
G6PC2XM_011511564.4 linkc.328+2007G>T intron_variant Intron 2 of 2 XP_011509866.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
G6PC2ENST00000375363.8 linkc.385G>T p.Ala129Ser missense_variant Exon 3 of 5 1 NM_021176.3 ENSP00000364512.3 Q9NQR9-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
0.00000685
AC:
10
AN:
1460244
Hom.:
0
Cov.:
29
AF XY:
0.00000688
AC XY:
5
AN XY:
726536
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33442
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39692
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00000810
AC:
9
AN:
1110510
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.440
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 26, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.385G>T (p.A129S) alteration is located in exon 3 (coding exon 3) of the G6PC2 gene. This alteration results from a G to T substitution at nucleotide position 385, causing the alanine (A) at amino acid position 129 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.096
BayesDel_addAF
Uncertain
0.034
T
BayesDel_noAF
Benign
-0.19
CADD
Benign
19
DANN
Benign
0.94
DEOGEN2
Uncertain
0.45
T;.
Eigen
Uncertain
0.23
Eigen_PC
Uncertain
0.31
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Uncertain
0.87
D;T
M_CAP
Benign
0.068
D
MetaRNN
Benign
0.29
T;T
MetaSVM
Uncertain
0.13
D
MutationAssessor
Benign
0.65
N;N
PhyloP100
3.3
PrimateAI
Uncertain
0.53
T
PROVEAN
Benign
-0.14
N;N
REVEL
Uncertain
0.31
Sift
Benign
0.73
T;T
Sift4G
Benign
0.68
T;T
Polyphen
0.92
P;.
Vest4
0.28
MutPred
0.63
Gain of glycosylation at A129 (P = 0.0312);Gain of glycosylation at A129 (P = 0.0312);
MVP
0.65
MPC
0.071
ClinPred
0.59
D
GERP RS
5.8
Varity_R
0.11
gMVP
0.39
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs747642704; hg19: chr2-169761071; API